Fonte: European Journal of Medicinal Chemistry. Unidade: IFSC
Assuntos: DOENÇA DE CHAGAS, PLANEJAMENTO DE FÁRMACOS, TRYPANOSOMA CRUZI
ABNT
REZENDE JUNIOR, Celso de Oliveira et al. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease. European Journal of Medicinal Chemistry, v. 246, n. Ja 2023, p. 114925-1-114925-10 + supplementary data, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2022.114925. Acesso em: 18 nov. 2024.APA
Rezende Junior, C. de O., Martinez, P. D. G., Ferreira, R. A. A., Koovits, P. J., Soares, B. M., Ferreira, L. L. G., et al. (2023). Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease. European Journal of Medicinal Chemistry, 246( Ja 2023), 114925-1-114925-10 + supplementary data. doi:10.1016/j.ejmech.2022.114925NLM
Rezende Junior C de O, Martinez PDG, Ferreira RAA, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Matheeussen A, Van Pelt N, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease [Internet]. European Journal of Medicinal Chemistry. 2023 ; 246( Ja 2023): 114925-1-114925-10 + supplementary data.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114925Vancouver
Rezende Junior C de O, Martinez PDG, Ferreira RAA, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Matheeussen A, Van Pelt N, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease [Internet]. European Journal of Medicinal Chemistry. 2023 ; 246( Ja 2023): 114925-1-114925-10 + supplementary data.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114925